Similar experiments using primary patient MLL-translocated AML cells from five separate patients yielded similar results, with upregulation of multiple myeloid-lineage markers, increased apoptosis, and reduced clonogenic potential (Figures 7E–7G; Table S1). This evidence concerns the gene KMT2A and acute myeloid leukemia.